Clin Mol Hepatol.
2025 Apr;31(2):577-580. 10.3350/cmh.2024.0661.
From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
- Affiliations
-
- 1Department of Hepatology, Institute of Liver and Biliary Sciences, Delhi, India
- KMID: 2566977
- DOI: http://doi.org/10.3350/cmh.2024.0661
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correspondence to editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
- Severe carvedilol toxicity without overdose – caution in cirrhosis
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
- Pathophysiology and diagnosis of portal hypertension
